| Systematic (IUPAC) name | |
|---|---|
| 2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine | |
| Clinical data | |
| MedlinePlus | a682065 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Pharmacokinetic data | |
| Bioavailability | High |
| Protein binding | 96% |
| Metabolism | Mostly hepatic (CYP-mediated), also renal |
| Half-life | 1 to 4 hours |
| Identifiers | |
| CAS number | 1808-12-4 |
| ATC code | R06AA01 |
| PubChem | CID 2444 |
| DrugBank | DB01237 |
| ChemSpider | 2350 |
| UNII | 202J683U97 |
| ChEBI | CHEBI:59177 |
| ChEMBL | CHEMBL1201245 |
| Chemical data | |
| Formula | C17H20BrNO |
| Mol. mass | 334.251 g/mol |
|
|
|
|
| |
|
Bromazine (Ambrodyl, Ambrodil and others), also known as bromodiphenhydramine, is an antihistamine and anticholinergic. It is a halogenated form of diphenhydramine and in many respects is somewhat stronger than the parent compound.
|
||||||||||||||||||||||||||||||||||
| This article about an amine is a stub. You can help Wikipedia by expanding it. |
| This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
Here you can share your comments or contribute with more information, content, resources or links about this topic.